Multi-antigen vectors for melanoma

Details for Australian Patent Application No. 2011200127 (hide)

Owner Sanofi Pasteur Limited Therion Biologics, Inc.

Inventors Panicali, Dennis; Tartaglia, Jim; Gritz, Linda; Parrington, Mark; Berinstein, Neil

Agent Spruson & Ferguson

Pub. Number AU-B-2011200127

Parent 2004273034

Filing date 13 January 2011

Wipo publication date 3 February 2011

Acceptance publication date 21 June 2012

International Classifications

C07K 14/47 Peptides having more than 20 amino acids

A61K 39/00 Medicinal preparations containing antigens or antibodies

C12N 15/863 Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

Event Publications

27 January 2011 Complete Application Filed

3 February 2011 Application Open to Public Inspection

  Published as AU-B-2011200127

21 June 2012 Application Accepted

  Published as AU-B-2011200127

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200128-Skin equivalent culture

2011200126-Disposable circumcision device